S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.0149 SEK 2.05%
Market Cap: 12.5m SEK
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one S2M stock under the Base Case scenario is 0.0305 SEK. Compared to the current market price of 0.0149 SEK, S2Medical AB (publ) is Undervalued by 51%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

S2M Relative Value
Base Case
0.0305 SEK
Undervaluation 51%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

0.8
P/S
P/S
Price to Sales
0.8
vs History
85
vs Industry
70
Median 3Y
1.7
Median 5Y
1.7
Industry
2.3
More Details
2.2
P/E
P/E
Price to Earnings
2.2
vs History
3
vs Industry
Median 3Y
-0.8
Median 5Y
-1.1
Industry
22
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
56
Median 3Y
-0.8
Median 5Y
-1.3
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-1.2
Industry
20
More Details
1.1
P/B
P/B
Price to Book Value
1.1
vs History
76
vs Industry
68
Median 3Y
1.4
Median 5Y
1.3
Industry
2.2
More Details
0.8
EV/S
EV/S
Enterprise Value to Sales
0.8
vs History
74
vs Industry
75
Median 3Y
1
Median 5Y
1
Industry
2.4
More Details
0.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.8
vs History
76
vs Industry
83
Median 3Y
1
Median 5Y
1.8
Industry
5
More Details
1.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
1.7
vs History
7
vs Industry
54
Median 3Y
-0.3
Median 5Y
-0.8
Industry
11.6
More Details
2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
2
vs History
9
vs Industry
49
Median 3Y
-0.2
Median 5Y
-0.7
Industry
15.9
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
57
Median 3Y
-0.7
Median 5Y
-0.9
Industry
14.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
46
Median 3Y
-0.7
Median 5Y
-0.8
Industry
18
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
63
vs Industry
78
Median 3Y
0.6
Median 5Y
0.9
Industry
1.8
More Details

Multiples Across Competitors

S2M Competitors Multiples
S2Medical AB (publ) Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
S2Medical AB (publ)
STO:S2M
12.6m SEK 0.8 2.2 1.7 2
CH
Alcon AG
SIX:ALC
34.9B CHF 4.4 38.9 17.9 33.8
JP
Hoya Corp
TSE:7741
6.3T JPY 7.3 31.2 19.2 23
DK
Coloplast A/S
CSE:COLO B
136.7B DKK 4.9 30.2 17.4 20.5
US
Align Technology Inc
NASDAQ:ALGN
14B USD 3.5 34.3 16.4 20.2
CH
Ypsomed Holding AG
SIX:YPSN
5.9B CHF 7.8 67.2 32.1 54.8
UK
ConvaTec Group PLC
LSE:CTEC
4.9B GBP 2.9 34.9 207.9 340.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.7B CNY 12.1 30.6 26.3 26.3
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.1B USD 3.3 20 9.2 10.5
KR
HLB Inc
KOSDAQ:028300
7.1T KRW 94.9 -37.6 -66.7 -63.1
CA
Bausch + Lomb Corp
NYSE:BLCO
5B USD 1 -13.8 17.2 75.6
P/E Multiple
Earnings Growth PEG
SE
S
S2Medical AB (publ)
STO:S2M
Average P/E: 32.2
2.2
N/A N/A
CH
Alcon AG
SIX:ALC
38.9
28%
1.4
JP
Hoya Corp
TSE:7741
31.2
N/A N/A
DK
Coloplast A/S
CSE:COLO B
30.2
14%
2.2
US
Align Technology Inc
NASDAQ:ALGN
34.3
30%
1.1
CH
Ypsomed Holding AG
SIX:YPSN
67.2
N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
34.9
33%
1.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
30.6
20%
1.5
US
Lantheus Holdings Inc
NASDAQ:LNTH
20
25%
0.8
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -37.6 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -13.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
S
S2Medical AB (publ)
STO:S2M
Average EV/EBITDA: 36.5
1.7
N/A N/A
CH
Alcon AG
SIX:ALC
17.9
10%
1.8
JP
Hoya Corp
TSE:7741
19.2
9%
2.1
DK
Coloplast A/S
CSE:COLO B
17.4
9%
1.9
US
Align Technology Inc
NASDAQ:ALGN
16.4
15%
1.1
CH
Ypsomed Holding AG
SIX:YPSN
32.1
N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
207.9
11%
18.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26.3
18%
1.5
US
Lantheus Holdings Inc
NASDAQ:LNTH
9.2
21%
0.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -66.7 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
17.2
19%
0.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
S
S2Medical AB (publ)
STO:S2M
Average EV/EBIT: 60.7
2
N/A N/A
CH
Alcon AG
SIX:ALC
33.8
25%
1.4
JP
Hoya Corp
TSE:7741
23
N/A N/A
DK
Coloplast A/S
CSE:COLO B
20.5
9%
2.3
US
Align Technology Inc
NASDAQ:ALGN
20.2
17%
1.2
CH
Ypsomed Holding AG
SIX:YPSN
54.8
N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
340.1
22%
15.5
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26.3
16%
1.6
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.5
22%
0.5
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -63.1 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
75.6
55%
1.4

See Also

Summary
S2M intrinsic value, competitors valuation, and company profile.
DCF Valuation
S2M stock valuation using Discount Cash Flow valuation method.
Relative Valuation
S2M stock valuation using valuation multiples.
Wall Street Estimates
S2M price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
S2M stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 268,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.